Century Therapeutics (IPSC) Change in Accured Expenses (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Change in Accured Expenses of -$4.0 million for Q1 2026, up 39.55% year-over-year from -$2.8 million in Q1 2025, and down 466.64% quarter-over-quarter from $1.1 million in Q4 2025.
Century Therapeutics (IPSC) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Change in Accured Expenses for 7 consecutive years, with -$4.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 39.55% year-over-year to -$4.0 million; the TTM figure through Mar 2026 stood at -$1.7 million (down 6.41% YoY), while the FY2025 annual figure was -$4.3 million, down 369.35% from the prior year.
- Change in Accured Expenses slipped to -$4.0 million in Q1 2026 per IPSC's latest filing, from $1.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.9 million in Q3 2023 and bottomed at -$6.5 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged -$202470.6 across 5 years, with a median of $707000.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses tumbled 310.87% — and 2025, when it surged 397.06%.
- Century Therapeutics' Change in Accured Expenses stood at $1.1 million in 2022, then sank by 310.87% to -$2.4 million in 2023, then soared by 221.74% to $2.9 million in 2024, then plunged by 62.87% to $1.1 million in 2025, then tumbled by 466.64% to -$4.0 million in 2026.
- Business Quant data shows IPSC's Change in Accured Expenses at -$4.0 million in Q1 2026, $1.1 million in Q4 2025, and $443000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 55.78 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 212.44 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 61.62 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Mn |
| Jun 30, 2026 | 1.16 Mn |
| Mar 31, 2026 | -3.96 Mn |
| Mar 31, 2026 | -3.96 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 443,000.00 |
| Sep 30, 2025 | 443,000.00 |
| Jun 30, 2025 | 707,000.00 |
| Jun 30, 2025 | 707,000.00 |
| Mar 31, 2025 | -6.54 Mn |
| Mar 31, 2025 | -6.54 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | -238,000.00 |
| Jun 30, 2024 | -238,000.00 |
| Mar 31, 2024 | -3.32 Mn |
| Mar 31, 2024 | -3.32 Mn |